Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Shwachman-Diamond Syndrome: early-phase trial registry
3 of 4 indexed Shwachman-Diamond Syndrome trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Shwachman-Diamond Syndrome: 4 US clinical trials tracked, 3 recruiting.
Shwachman-Diamond Syndrome is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Shwachman-Diamond Syndrome Alliance, running 1 of these trials.
Enrollment posture brief
Registry condition shwachman-diamond-syndrome
OPEN 3 | RECR 75% | LATE 0 | EARLY 1 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)
Shwachman-Diamond Syndrome lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Shwachman-Diamond Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Shwachman-Diamond Syndrome is recruiting above its size-band peers.
3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform
Shwachman-Diamond Syndrome Alliance
NCT06999954
Shwachman Diamond Syndrome Registry and Study
Boston Children's Hospital
NCT06056908
Cancer in Inherited Bone Marrow Failure Syndromes
National Cancer Institute (NCI)
NCT00027274
Stem Cell Transplant for Hemoglobinopathy
Masonic Cancer Center, University of Minnesota
NCT00176852
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Shwachman-Diamond Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Shwachman-Diamond Syndrome trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Shwachman-Diamond Syndrome page
4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Shwachman-Diamond Syndrome trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Shwachman-Diamond Syndrome Alliance sponsors the most Shwachman-Diamond Syndrome trials on record, review their full trial history before evaluating a specific study. See Shwachman-Diamond Syndrome Alliance's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Shwachman-Diamond Syndrome condition card totals 4 registered trials; most-linked intervention Campath, Fludarabine, Cyclophosphamide; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.